Johnson & Johnson announced late Saturday that it's "assuming full responsibility" for manufacturing its COVID-19 vaccine at a Baltimore plant where 15 million doses were ruined last week.
Of note: AstraZeneca said Saturday night it is in "full cooperation with the U.S. government" moving production from the facility, run by Emergent BioSolutions, which been producing both vaccines.
Of note: Fernández received his first dose of Russia’s Sputnik V coronavirus vaccine on Jan. 21 and the second on Feb. 11, per the Wall Street Journal.
Like people in a pandemic winter, periodical cicadas are waiting for the warmer weather of spring.
What's happening: In a few weeks, billions of the insects are predicted to emerge in parts of the eastern U.S. after 17 years — and the vast majority of their life — underground.
A leading synthetic biology company is using bioengineering to try to create more resilient crops.
Why it matters: Extreme weather and a 7.8 billion-and-growing global population are ratcheting up pressure on an already fragile food system — and the environments that support it.
Companies are rapidly designing private space stations that could one day dominate operations in orbit around Earth.
Why it matters: NASA is hoping private industry will start to take over operations in low-Earth orbit once the International Space Station comes to an end, creating a robust commercial market in that part of space.